Annovis Bio (ANVS)
(Real Time Quote from BATS)
$8.11 USD
-0.36 (-4.25%)
Updated Sep 23, 2024 03:53 PM ET
After-Market: $8.00 -0.11 (-1.36%) 4:16 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
Annovis Bio, Inc. (ANVS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$32.40 | $72.00 | $13.00 | 282.53% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Annovis Bio, Inc. comes to $32.40. The forecasts range from a low of $13.00 to a high of $72.00. The average price target represents an increase of 282.53% from the last closing price of $8.47.
Analyst Price Targets (5 )
Broker Rating
Annovis Bio, Inc. currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, four are Strong Buy, representing 66.67% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.67 | 1.67 | 1.80 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/13/2024 | EF Hutton Financial | Jason Kolbert | Not Available | Strong Buy |
7/11/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Strong Buy | Strong Buy |
5/3/2024 | Maxim Group | Jason Mccarthy | Strong Buy | Hold |
4/30/2024 | Canaccord Genuity | Sumant Kulkarni | Strong Buy | Strong Buy |
2/28/2024 | Brookline Capital Markets | Tyler Bussian | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 6 |
Average Target Price | $32.40 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.64 |
ANVS FAQs
Annovis Bio, Inc. (ANVS) currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Annovis Bio, Inc. (ANVS) is $32.40. The current on short-term price targets is based on 3 reports.
The forecasts for Annovis Bio, Inc. (ANVS) range from a low of $13 to a high of $72. The average price target represents a increase of $282.53 from the last closing price of $8.47.
The current UPSIDE for Annovis Bio, Inc. (ANVS) is 282.53%
Based on short-term price targets offered by five analysts, the average price target for Annovis Bio, Inc. comes to $32.40. The forecasts range from a low of $13.00 to a high of $72.00. The average price target represents an increase of 282.53% from the last closing price of $8.47.